Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

University of Guelph

$42,453.00

Dietary choline and betaine in the prevention and treatment of feline obesity

FY 2021-22

Summary
With a prevalence of more than 50% in industrialised countries, obesity represents a major health risk for the feline population, especially as obese cats are predisposed to devastating health complications that have a large negative impact on the quality of life and reduce life span. Moreover, current spay/neuter practices are known to be a major risk factor for fat deposition and development of obesity. Weight reduction is recommended in overweight cats yet current weight-loss programs tend to have disappointing outcomes and are not without risks. During periods of severe energy restriction, obesity predisposes cats to hepatic lipidosis, which is characterized by fat accumulation in the liver. Although the precise pathogenesis remains a mystery, it is believed that specific characteristics of feline protein and fat metabolism are involved. Dietary choline and betaine are metabolically linked to fat metabolism and may pose a benefit when treating and preventing obesity in cats. Choline as the precursor of phosphatidylcholine, a structural component of very-low-density lipoproteins, accelerates the removal of fat from the liver. Furthermore, choline and its derivate betaine, being methyl group donors, enhance the hepatic synthesis of carnitine, which is known to promote fat oxidation. In livestock, betaine not only reduces fat accumulation in the liver, but also decreases abdominal storage of fat and improves carcass lean percentage. The objective of this research is to investigate the effect of dietary choline and betaine supplementation on energy and lipid metabolism in obese cats during an episode of energy restriction and in growing kittens following spay/neuter. This university-government-industry partnership will support future pet nutrition research opportunities and growth of the domestic and export pet food markets. Comprehensive understanding of the molecular mechanisms of pet obesity and how these mechanisms are affected by functional foods that uncouple energy metabolism will lead to the development of new nutritional strategies that will make maintaining an ideal body weight much easier, prevent obesity and related health consequences and improve lifespan and quality of life of pets.
Program
Collaborative Research and Development Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
472710-2016
Name nom
Verbrugghe, Adronie
Department département
Clinical Studies
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2016
Award amount
42453
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5511
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal nutrition and husbandry
Research subject fr
Nutrition et élevage des animaux
Installment
inst:6
Partie
1
Nb partie
6
Application title
Dietary choline and betaine in the prevention and treatment of feline obesity
Keyword
NSERC
Application summary
With a prevalence of more than 50% in industrialised countries, obesity represents a major health risk for the feline population, especially as obese cats are predisposed to devastating health complications that have a large negative impact on the quality of life and reduce life span. Moreover, current spay/neuter practices are known to be a major risk factor for fat deposition and development of obesity. Weight reduction is recommended in overweight cats yet current weight-loss programs tend to have disappointing outcomes and are not without risks. During periods of severe energy restriction, obesity predisposes cats to hepatic lipidosis, which is characterized by fat accumulation in the liver. Although the precise pathogenesis remains a mystery, it is believed that specific characteristics of feline protein and fat metabolism are involved. Dietary choline and betaine are metabolically linked to fat metabolism and may pose a benefit when treating and preventing obesity in cats. Choline as the precursor of phosphatidylcholine, a structural component of very-low-density lipoproteins, accelerates the removal of fat from the liver. Furthermore, choline and its derivate betaine, being methyl group donors, enhance the hepatic synthesis of carnitine, which is known to promote fat oxidation. In livestock, betaine not only reduces fat accumulation in the liver, but also decreases abdominal storage of fat and improves carcass lean percentage. The objective of this research is to investigate the effect of dietary choline and betaine supplementation on energy and lipid metabolism in obese cats during an episode of energy restriction and in growing kittens following spay/neuter. This university-government-industry partnership will support future pet nutrition research opportunities and growth of the domestic and export pet food markets. Comprehensive understanding of the molecular mechanisms of pet obesity and how these mechanisms are affected by functional foods that uncouple energy metabolism will lead to the development of new nutritional strategies that will make maintaining an ideal body weight much easier, prevent obesity and related health consequences and improve lifespan and quality of life of pets.